Drug Shortage Report for APO-TERAZOSIN
Report ID | 36353 |
Drug Identification Number | 02234504 |
Brand name | APO-TERAZOSIN |
Common or Proper name | TERAZOSIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TERAZOSIN |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-15 |
Estimated end date | 2018-08-31 |
Actual end date | 2018-07-30 |
Shortage status | Resolved |
Updated date | 2018-07-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-01-17 | English | Compare |
v2 | 2018-01-17 | French | Compare |
v3 | 2018-02-12 | English | Compare |
v4 | 2018-02-12 | French | Compare |
v5 | 2018-04-02 | English | Compare |
v6 | 2018-04-02 | French | Compare |
v7 | 2018-07-04 | English | Compare |
v8 | 2018-07-04 | French | Compare |
v9 | 2018-07-30 | English | Compare |
v10 | 2018-07-30 | French | Compare |
v11 | 2018-07-31 | English | Compare |
Showing 1 to 11 of 11